Rory B. Riggs - 16 Mar 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
16 Mar 2022
Net transactions value
-$13,623,979
Form type
4
Filing time
18 Mar 2022, 20:12:36 UTC
Previous filing
04 Jan 2022
Next filing
21 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale $1,214,771 -20,686 -9.1% $58.72 205,984 16 Mar 2022 Held by New Ventures I, LLC F1, F2
transaction ITCI Common Stock Sale $2,610,057 -43,848 -21% $59.53 162,136 16 Mar 2022 Held by New Ventures I, LLC F2, F3
transaction ITCI Common Stock Sale $1,595,076 -26,587 -16% $59.99 135,549 17 Mar 2022 Held by New Ventures I, LLC F2, F4
transaction ITCI Common Stock Sale $6,941,570 -114,912 -85% $60.41 20,637 17 Mar 2022 Held by New Ventures I, LLC F2, F5
transaction ITCI Common Stock Sale $297,154 -4,901 -24% $60.63 15,736 18 Mar 2022 Held by New Ventures I, LLC F2, F6
transaction ITCI Common Stock Sale $965,352 -15,736 -100% $61.35 0 18 Mar 2022 Held by New Ventures I, LLC F2, F7
holding ITCI Common Stock 76,815 16 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $60.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.21 to $60.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.